Related Experiment Video
Updated: May 25, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Validation of an automatic dose injection system for Ictal SPECT in epilepsy
Xavier Setoain1, Javier Pavía, Eulalia Serés
1Diagnostic Imaging Centre, Hospital Clínic de Barcelona, Barcelona, Spain. setoain@clinic.ub.es
Summary
An automated injector system (AIS) for ictal SPECT reduces injection time and improves accuracy in epilepsy patients. This technology enhances nursing staff efficiency and precision in seizure focus localization.
Area of Science:
- Neurology
- Medical Imaging
- Biomedical Engineering
Background:
- Epilepsy diagnosis relies on accurately localizing the seizure focus.
- Ictal SPECT, often combined with SISCOM, is a key tool for this localization.
- Manual injection of radioactive tracers can be imprecise and time-consuming.
Purpose of the Study:
- To evaluate the performance and clinical utility of an automated injector system (AIS).
- To compare AIS with manual injection (MI) for ictal SPECT in drug-resistant epilepsy patients.
Main Methods:
- The study involved 56 patients with drug-resistant, complex partial seizures.
- Automated injection (AIS) was used in 27 patients; manual injection (MI) in 29.
- Injection time and seizure focus localization accuracy (using SPECT/SISCOM) were compared.
Main Results:
- AIS demonstrated a significantly lower injection time (33s vs 41s) compared to MI.
- No system failures occurred with AIS during experimental or clinical phases.
- While AIS showed a trend towards improved focus localization (78% vs 65%), the difference was not statistically significant (P=0.14). Nursing staff found AIS more convenient.
Conclusions:
- AIS offers improved precision in tracer injection and enhances nursing staff efficiency.
- The system has the potential to reduce injection time and improve SPECT accuracy for seizure focus localization.
